B 
42.97
+3.84%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue, before interest expense
$76.13bn
FY2016FY2025
Net income
$1.31bn
FY2016FY2025
Total assets
$518.97bn
FY2016FY2025
Shareholders' equity
$47.80bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue, before interest expense | $76.13bn | $86.01bn | $95.92bn | $92.77bn | $75.73bn | $62.75bn | $67.83bn | $56.77bn | $40.79bn | $24.41bn |
| Research and development | — | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $21.47bn | $19.45bn | $20.86bn | $17.37bn | $19.22bn | $9.47bn | $13.08bn | $8.05bn | $5.96bn | $4.58bn |
| Net income | $1.31bn | $641.0m | $1.13bn | $2.06bn | $3.97bn | −$134.0m | $2.81bn | $3.58bn | $1.46bn | $1.65bn |
| Diluted earnings per share | 0.55 | 0.27 | 0.48 | 1.31 | 2.44 | -0.06 | 1.21 | 1.63 | 0.66 | 0.59 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $518.97bn | $490.42bn | $490.10bn | $441.28bn | $391.00bn | $343.70bn | $323.97bn | $256.28bn | $192.72bn | $159.83bn |
| Cash and short-term investments | $16.24bn | $20.18bn | $16.89bn | $21.96bn | $19.66bn | $9.93bn | $6.78bn | $11.77bn | $5.14bn | $7.53bn |
| Total liabilities | $352.78bn | $325.04bn | $321.85bn | $299.39bn | $256.26bn | $221.05bn | $207.12bn | $159.13bn | $112.85bn | $90.14bn |
| Debt | $259.61bn | $249.21bn | $246.47bn | $225.65bn | $187.74bn | $158.87bn | $159.60bn | $120.62bn | $80.64bn | $67.05bn |
| Shareholders' equity | $47.80bn | $45.98bn | $45.78bn | $141.89bn | $134.74bn | $122.64bn | $116.85bn | $29.82bn | $79.87bn | $69.69bn |
| Shares outstanding | 2,367m | 2,384m | 2,371m | 1,575m | 1,627m | 2,311m | 2,326m | 2,196m | 2,213m | 2,780m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue, before interest expense | $19.28bn | $18.39bn | $21.18bn | $18.92bn | $18.08bn | $17.94bn | $19.43bn | $20.62bn |
| Operating income | $4.67bn | $4.39bn | $8.88bn | $5.10bn | $4.15bn | $4.76bn | $5.01bn | $5.26bn |
| Net income | $354.8m | $100.6m | $743.0m | $219.0m | $272.0m | $73.0m | $432.0m | $64.0m |
| Diluted earnings per share | 0.21 | 0.06 | 0.31 | 0.09 | 0.11 | 0.03 | 0.18 | 0.03 |
| Total assets | $524.88bn | $521.32bn | $518.97bn | $514.59bn | $506.07bn | $491.58bn | $490.42bn | $508.14bn |
| Cash and short-term investments | $14.87bn | $15.08bn | $16.24bn | $25.39bn | $22.85bn | $12.44bn | $20.18bn | $18.20bn |
| Debt | — | $263.84bn | $308.80bn | $259.21bn | $250.63bn | $209.19bn | $234.30bn | $281.27bn |
| Shareholders' equity | $46.52bn | $46.94bn | $47.80bn | $46.66bn | $46.60bn | $45.27bn | $45.98bn | $46.47bn |
Financial ratios
Data as of 8 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Operating margin | 28.2% | 22.6% | 21.7% | 18.7% | 25.4% | 15.1% | — | — |
| Net margin | 1.7% | 0.7% | 1.2% | 2.2% | 5.2% | -0.2% | — | — |
| Return on equity | 2.7% | 1.4% | 2.5% | 1.4% | 2.9% | -0.1% | — | — |
| Return on assets | 0.3% | 0.1% | 0.2% | 0.5% | 1.0% | -0.0% | — | — |
| Revenue growth | -11.5% | -10.3% | 3.4% | 22.5% | 20.7% | -7.5% | — | — |
| Earnings growth | 103.9% | -43.3% | -45.0% | -48.2% | -3059.7% | -104.8% | — | — |
| Current ratio | 1.14x | 0.65x | 0.51x | 0.69x | 0.86x | 0.85x | — | — |
| Debt to equity | 6.46x | 5.11x | 5.11x | 1.82x | 1.31x | 1.21x | — | — |
| Equity ratio | 9.2% | 9.4% | 9.3% | 32.2% | 34.5% | 35.7% | — | — |
| Interest coverage | 1.26x | 1.17x | 1.35x | 1.62x | 2.53x | 1.31x | — | — |
| R&D as a share of sales | — | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Buybacks as a share of market value | 0.7% | -0.5% | -50.6% | 3.2% | 29.6% | 0.6% | — | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -6.4% | 3.9% | 14.4% |
| Operating income | 7.3% | 17.8% | 19.3% |
| Net income | -14.0% | — | -5.7% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | 25.2% | 22.6% | 22.0% | 20.5% |
| Net margin | 1.2% | 1.5% | 1.8% | 3.0% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 83.1 | 142.4 | 56.1 | 16.1 | 13.4 | -383.8 | 17.1 | 8.4 | 23.5 | 19.8 |
| Price to sales | 1.4 | 1.1 | 0.7 | 0.4 | 0.7 | 0.8 | 0.7 | 0.5 | 0.8 | 1.3 |
Market value over time
31 Oct 2016 to 4 Sept 2026, in USD
$27.69bn$95.41bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | 21% | 41% | 25% | -32% | 44% | 3% | 52% | -11% | 28% | 13% |
Dividends and splits
Per share, in the currency the company pays
Paid for 26 years. Last went ex-dividend on 14 Sept 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 0.21 | 0.24 | 0.213 | 0.187 | 0.302 | 0.279 | 0.257 | 0.228 |
- 3-for-2 split · 10 Oct 2025
- 1-to-1 reverse split · 16 Nov 2023
- 1-to-1 reverse split · 13 Nov 2023
- 3-for-2 split · 2 Apr 2020
- 3-for-2 split · 13 May 2015
- 3-for-2 split · 4 Jun 2007
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.